XML 16 R7.htm IDEA: XBRL DOCUMENT v3.23.3Close
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Cash flows from operating activities    
Net income $ 3,024 $ 2,820
Adjustments to reconcile net income to net cash provided by operating activities:    
Gain on sale of Gentiva Hospice 0 (240)
Loss on investment securities, net 49 136
Equity in net losses (earnings) 39 (1)
Stock-based compensation 142 173
Depreciation 628 555
Amortization 51 73
Impairment of property and equipment 31 144
Deferred income taxes 0 (33)
Changes in operating assets and liabilities, net of effect of businesses acquired and disposed:    
Receivables (126) 11
Other assets (935) (465)
Benefits payable 870 948
Other liabilities 39 (195)
Unearned revenues 7,250 5,758
Other 53 30
Net cash provided by operating activities 11,115 9,714 Close
Cash flows from investing activities    
Proceeds from sale of Gentiva Hospice, net 0 2,708
Acquisitions, net of cash and cash equivalents acquired (223) (293)
Purchases of property and equipment, net (721) (862)
Purchases of investment securities (3,366) (4,740)
Proceeds from maturities of investment securities 885 1,214
Proceeds from sales of investment securities 815 1,979
Net cash (used in) provided by investing activities (2,610) 6 Close
Cash flows from financing activities    
Receipts from contract deposits, net 2,481 3,787
Proceeds from issuance of senior notes, net 1,215 744
Repayments of senior notes (1,719) 0
Proceeds from issuance (repayments) of commercial paper, net 1,618 (660)
Repayment of term loan (500) (2,000)
Debt issue costs (4) (2)
Change in book overdraft (52) (89)
Common stock repurchases (1,002) (1,032)
Dividends paid (320) (291)
Other (135) (13)
Net cash provided by financing activities 1,582 444 Close
Increase in cash and cash equivalents 10,087 10,164 Close
Cash and cash equivalents at beginning of period 5,061 3,394
Cash and cash equivalents at end of period 15,148 13,558
Supplemental cash flow disclosures:    
Interest payments 317 256
Income tax payments, net 957 751
Details of businesses acquired in purchase transactions:    
Fair value of assets acquired, net of cash and cash equivalents acquired 454 411
Less: Fair value of liabilities assumed (236) (65)
Less: Noncontrolling interests acquired 5 (53)
Cash paid for acquired businesses, net of cash and cash equivalents acquired $ 223 $ 293